Shares of R1 RCM Inc (NYSE:RCM) have been given a consensus broker rating score of 2.33 (Buy) from the three brokers that provide coverage for the company, Zacks Investment Research reports. Two research analysts have rated the stock with a hold recommendation and one has issued a strong buy recommendation on the company.

Brokerages have set a 1-year consensus price target of $4.68 for the company and are expecting that the company will post ($0.01) EPS for the current quarter, according to Zacks. Zacks has also assigned R1 RCM an industry rank of 175 out of 265 based on the ratings given to related companies.

A number of analysts recently weighed in on RCM shares. Zacks Investment Research cut shares of R1 RCM from a “buy” rating to a “hold” rating in a report on Friday, July 7th. Robert W. Baird restated a “hold” rating and set a $5.00 target price on shares of R1 RCM in a report on Thursday, August 24th.

Shares of R1 RCM (NYSE:RCM) traded up 1.23% during trading on Wednesday, hitting $3.28. The company’s stock had a trading volume of 40,216 shares. R1 RCM has a one year low of $1.75 and a one year high of $4.37. The company has a 50-day moving average price of $3.38 and a 200-day moving average price of $3.81.

R1 RCM (NYSE:RCM) last issued its earnings results on Wednesday, August 2nd. The company reported ($0.11) earnings per share for the quarter, missing the Zacks’ consensus estimate of ($0.04) by $0.07. The business had revenue of $99.40 million for the quarter, compared to the consensus estimate of $91.95 million. R1 RCM had a negative return on equity of 51.77% and a negative net margin of 6.74%. Equities analysts anticipate that R1 RCM will post ($0.04) earnings per share for the current fiscal year.

A number of hedge funds have recently modified their holdings of the company. Spark Investment Management LLC boosted its stake in shares of R1 RCM by 195.4% in the second quarter. Spark Investment Management LLC now owns 379,900 shares of the company’s stock worth $1,424,000 after buying an additional 251,300 shares during the last quarter. New York State Common Retirement Fund purchased a new position in R1 RCM during the second quarter worth approximately $305,000. Nationwide Fund Advisors purchased a new position in R1 RCM during the second quarter worth approximately $215,000. SLS Management LLC raised its position in R1 RCM by 1.8% in the second quarter. SLS Management LLC now owns 631,210 shares of the company’s stock worth $2,367,000 after buying an additional 11,300 shares in the last quarter. Finally, TIAA CREF Investment Management LLC purchased a new position in R1 RCM during the second quarter worth approximately $1,014,000.

COPYRIGHT VIOLATION NOTICE: “R1 RCM Inc (RCM) Receives Consensus Rating of “” from Analysts” was first posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this piece of content on another site, it was stolen and republished in violation of international copyright and trademark law. The legal version of this piece of content can be accessed at https://www.thecerbatgem.com/2017/08/30/r1-rcm-inc-rcm-receives-consensus-rating-of-from-analysts.html.

About R1 RCM

R1 RCM Inc, formerly Accretive Health, Inc, is a provider of revenue cycle management (RCM) and physician advisory services (PAS) to healthcare providers. The Company is engaged in providing management services of revenue cycle operations for the United States-based hospitals and other medical services providers.

Get a free copy of the Zacks research report on R1 RCM (RCM)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Stock Ratings for R1 RCM Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for R1 RCM Inc and related stocks with our FREE daily email newsletter.